The Principal Investigator, Susan Feyerabend M.D., has conducted 130+ clinical trials in Urology at the Studienpraxis Urology in Nuertingen since 2009, respectively at the University of Tuebingen, where she headed the Clinical Oncologic Research Department in Urology 2003 until 2016.
Susan Feyerabend is widely recognized as a specialist in Urologic Oncology and Palliative Care. The Sub-Investigator, originally a Surgeon and A&E-specialist, has participated in dozens of clinical trials since 1996. Our study nurses are GCP trained and received extensive oncologic education.
Specialist Registrar Urology, specialization in Palliative Care, oncologic drug-therapy, Principal Investigator, Consultant Urologic Oncology Clinic for Urology of the University of Tuebingen
CVProf. Dr. Tilman Todenhöfer ist Facharzt für Urologie, Zusatzbezeichnung Medikamentöse Tumortherapie, leitender Prüfarzt. Als Oberarzt leitete er die Studienzentrale der Universitätsklinik für Urologie Tübingen zwischen 2015 und 2019
CV
Specialist Surgeon, specialization in Accident&Emergency, Sub-Investigator
CV